Corporate News     14-Jul-23
Gland Pharma's Dundigal Facility undergoes USFDA audit
Gland Pharma announced that the United States Food and Drug Administration (US FDA) has conducted Good Manufacturing Practice (GMP) Inspection at the Company's Dundigal Facility at Hyderabad between 03 July 2023 and 14 July 2023.

The inspection was concluded with ONE (1) 483 Observation. The corrective and preventive actions for this observation will be submitted to the US FDA within the stipulated period. The observation issued is neither a repeated observation nor related to data integrity.

Previous News
  Gland Pharma Ltd spurts 3.45%, gains for third straight session
 ( Hot Pursuit - 09-Jul-24   13:06 )
  US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
 ( Hot Pursuit - 05-Aug-24   12:19 )
  Gland Pharma's Dundigal unit receives Establishment Inspection Report from USFDA
 ( Corporate News - 24-Aug-23   11:59 )
  Gland Pharma Dundigal facility gets EIR from USFDA
 ( Hot Pursuit - 24-Aug-23   12:15 )
  Gland Pharma
 ( Results - Analysis 24-Jan-23   11:02 )
  Gland Pharma gains after receiving EIR report for Hyderabad facility from USFDA
 ( Hot Pursuit - 26-Sep-23   11:28 )
  Gland Pharma's Pashamylaram facility clears USFDA inspection
 ( Corporate News - 26-Sep-23   11:46 )
  Gland Pharma
 ( Results - Analysis 23-May-24   10:29 )
  Board of Gland Pharma appoints Chief Operating Officer
 ( Corporate News - 07-Aug-23   17:15 )
  Gland Pharma allots 1800 equity shares under ESOS
 ( Corporate News - 24-Nov-22   18:34 )
  Gland Pharma allots 6,200 equity shares under ESOS
 ( Corporate News - 14-Feb-24   15:10 )
Other Stories
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
Back Top